You are here
L2 DIAGNOSTICS LLC
UEI: GKA7VH5LFR25
# of Employees: 15
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1
Amount: $988,360.00SUMMARY Arboviruses present a constant threat to human and animal health worldwide. They are transmitted by hematophagous arthropods, primarily mosquitoes. One of them, Aedes aegypti, is the primary v ...
STTRPhase II2022Department of Health and Human Services National Institutes of Health -
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1
Amount: $599,028.00ABSTRACTLyme disease, the most common vector-borne illness in North America, is caused by the spirochete B. burgdorferi. Infection begins in the skin following an infected tick-bite and acute illness ...
STTRPhase I2021Department of Health and Human Services National Institutes of Health -
Multiplexed Bioassay for Checkpoint Inhibitor Autoimmunity
Amount: $298,911.00The advent of checkpoint inhibitor (CPI) therapy in human cancer has dramatically changed the landscape of treatment strategies in recent years. Previously, cancers with largely ineffective therapeuti ...
STTRPhase I2020Department of Health and Human Services National Institutes of Health -
An antigen-detection assay to diagnose Babesia microti infection
Amount: $2,076,246.00PROJECT SUMMARY Human babesiosis is a malaria-like multisystem disease caused primarily by Babesia microti, an emerging apicomplexan parasite that infects and develops within human erythrocytes. The p ...
SBIRPhase II2020Department of Health and Human Services National Institutes of Health -
Vaccination against Zika virus infection using mosquito NeSt1 protein
Amount: $593,086.00Arthropod-borne viruses (arboviruses) present a substantial threat to human and animal health worldwide. They are transmitted by hematophagous arthropods, in which mosquitoes are one of the main trans ...
STTRPhase I2020Department of Health and Human Services National Institutes of Health -
A novel vaccine against mosquito-borne Zika virus based on mosquito salivary gland protein AgBR1
Amount: $594,226.00PROJECT SUMMARYZika virus, an emerging flavivirus, is associated with severe clinical outcomes, including Guillain-Barré syndrome and birth defects. Transmission of Zika virus is primarily mosquito- ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
Development of A Narrow Spectrum Anti-Tubercular Agent
Amount: $585,337.00Abstract Complex and lengthy treatment regimens coupled with rising drug resistance underscore the urgent need for new and better drugs to treat tuberculosis (TB) caused by the bacterium Mycobacterium ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Targets of Acquired Tick-Resistance As Anti-Tick Vaccines
Amount: $596,625.00ABSTRACTThis proposal seeks to develop a novel vaccine against pathogens transmitted by the blacklegged tick, Ixodes scapularis, by targeting tick salivary proteins (Salps) critical for tick feeding. ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
Immunization with mosquito AgTRIO protein to prevent malaria
Amount: $592,338.00PROJECT SUMMARYMalaria is one of the world’s major public health threats. The disease is transmitted when an infected female Anopheles mosquito, while probing for a blood meal, injects saliva togeth ...
STTRPhase I2019Department of Health and Human Services National Institutes of Health -
An antigen-detection assay to diagnose Babesia microti infection
Amount: $299,975.00Project Summary Human babesiosis is a malaria like multisystem disease caused primarily by Babesia microtian emerging apicomplexan parasite that infects and develops within human erythrocytesThe paras ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health
